Literature DB >> 6842230

Anticonvulsant serum levels: relationship to impairments of cognitive functioning.

P J Thompson, M R Trimble.   

Abstract

Twenty-eight patients with epilepsy were seen on two occasions at an interval of three months. On one session anticonvulsant serum levels were high and on the other session the serum levels were lower. On each of the two sessions patients performed a series of psychological tests and had a blood sample taken for the analysis of anticonvulsant serum concentrations. Seizure frequency in the previous three months was documented and several patients had an EEG recording made. Deficits in psychological test performance were found at high serum concentrations. Furthermore, lower serum level concentrations did not appear to be accompanied by worsened seizure control.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6842230      PMCID: PMC1027329          DOI: 10.1136/jnnp.46.3.227

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  Cognitive and motor-sensory performances in toxic and nontoxic epileptic subjects.

Authors:  C G Matthews; J P Harley
Journal:  Neurology       Date:  1975-02       Impact factor: 9.910

2.  Anticonvulsant drugs and mental symptoms: a review.

Authors:  M R Trimble; E H Reynolds
Journal:  Psychol Med       Date:  1976-05       Impact factor: 7.723

3.  Difference in the central actions of phenytoin and phenobarbitone in man, measured by critical flicker fusion threshold.

Authors:  G W Houghton; A N Latham; A Richens
Journal:  Eur J Clin Pharmacol       Date:  1973-06       Impact factor: 2.953

4.  Serum anticonvulsant concentrations in epileptic patients with mental symptoms. A preliminary report.

Authors:  E H Reynolds; R D Travers
Journal:  Br J Psychiatry       Date:  1974-05       Impact factor: 9.319

5.  Memory impairment in epileptic patients: selective effects of phenobarbital concentration.

Authors:  C M MacLeod; A S Dekabian; E Hunt
Journal:  Science       Date:  1978-12-08       Impact factor: 47.728

Review 6.  Serum levels of anticonvulsant drugs. Interpretation and clinical value.

Authors:  E H Reynolds
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310

7.  Diphenylhydantoin serum levels, toxicity, and neuropsychological performance in patients with epilepsy.

Authors:  C B Dodrill
Journal:  Epilepsia       Date:  1975-11       Impact factor: 5.864

8.  Anticonvulsant drugs and cognitive functions.

Authors:  P J Thompson; M R Trimble
Journal:  Epilepsia       Date:  1982-10       Impact factor: 5.864

9.  Phenytoin and cognitive function: effects on normal volunteers and implications for epilepsy.

Authors:  P Thompson; F A Huppert; M Trimble
Journal:  Br J Clin Psychol       Date:  1981-09

10.  Sodium valproate and cognitive functioning in normal volunteers.

Authors:  P J Thompson; M R Trimble
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

View more
  11 in total

1.  Effects of an acute seizure on associative learning and memory.

Authors:  Andrew J Holley; Joaquin N Lugo
Journal:  Epilepsy Behav       Date:  2015-12-03       Impact factor: 2.937

Review 2.  The risk-benefit ratio of anticonvulsant drugs.

Authors:  M J Eadie
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

3.  Cognitive Adverse Effects of Antiepileptic Drugs : Incidence, Mechanisms and Therapeutic Implications.

Authors:  R Kälviäinen; M Äikiä; P J Riekkinen
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

4.  Effect of Anacyclus pyrethrum on pentylenetetrazole-induced kindling, spatial memory, oxidative stress and rho-kinase II expression in mice.

Authors:  Monika Pahuja; Jogender Mehla; K H Reeta; Manjari Tripathi; Yogendra Kumar Gupta
Journal:  Neurochem Res       Date:  2012-12-15       Impact factor: 3.996

5.  Controlled evaluation of a supplementary dose of carbamazepine on psychomotor function in epileptic patients.

Authors:  G J Macphee; E M McPhail; E Butler; M J Brodie
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Cognitive development in epilepsy. The relative influence of epileptic activity and of brain damage.

Authors:  H Niemann; H E Boenick; R C Schmidt; G Ettlinger
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

7.  Effect of carbamazepine on psychomotor performance in näive subjects.

Authors:  G J MacPhee; C Goldie; D Roulston; L Potter; E Agnew; J Laidlaw; M J Brodie
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Phenobarbitone: adverse effects on reproductive performance and offspring development in the Mongolian gerbil, (Meriones unguiculatus).

Authors:  J B Chapman; M G Cutler
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

9.  Carbamazepine reduces memory induced activation of mesial temporal lobe structures: a pharmacological fMRI-study.

Authors:  H Jokeit; M Okujava; F G Woermann
Journal:  BMC Neurol       Date:  2001-12-18       Impact factor: 2.474

10.  Effect of oxcarbazepine on background EEG activity and cognition in epilepsy.

Authors:  Sung Min Kim; Jin-Young Song; Chany Lee; Hyang Woon Lee; Ji Young Kim; Seung Bong Hong; Ki-Young Jung
Journal:  J Epilepsy Res       Date:  2013-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.